$37.18
+0.23 (+0.62%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+138.49%
YTD
+43.50%
Open$37.23
Previous Close$36.95
Day High$37.49
Day Low$36.55
52W High$45.42
52W Low$14.58
Volume—
Avg Volume1.18M
Market Cap7.51B
P/E Ratio—
EPS$-2.81
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$25.99
Above
SMA 200
$19.59
Above
RSI (14)
49.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
23 analysts
Price Target
+63.9% upside
Current
$37.18
$37.18
Target
$60.94
$60.94
$43.15
$60.94 avg
$94.48
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.40B | 1.44B | 1.30B |
| Net Income | 261.90M | 339.04M | 251.92M |
| Profit Margin | 18.7% | 23.6% | 19.4% |
| EBITDA | 403.28M | 390.65M | 352.93M |
| Free Cash Flow | 259.22M | 284.01M | 237.35M |
| Rev Growth | +1.7% | -7.0% | +15.8% |
| Debt/Equity | 0.75 | 0.69 | 0.65 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |